rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Rallybio Corporation

RLYB · Nasdaq

Health CareBiotechnologyLeading

RLYB stood above a rising 150-day average in 47 of the last 52 weekly readings, including each of the last 35 weeks. It is 12.8% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
35 in a row
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$8.5M
Insider sales, 12 months
$7,985
Officials’ trades on record
0
Institutions holding
37 (+1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 47 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$8.2MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months12
Sale orders, 12 months1
Buyers · sellers2 · 1
WhoDidSharesTraded
Adar1 Capital Management, Llc10% ownerbought10,000at $13.9819 May 2026filed 20 May 2026
Adar1 Capital Management, Llc10% ownerbought200at $13.8019 May 2026filed 20 May 2026
Adar1 Capital Management, Llc10% ownerbought6,009at $13.9818 May 2026filed 20 May 2026
Adar1 Capital Management, Llc10% ownerbought100at $13.8015 May 2026filed 15 May 2026
Adar1 Capital Management, Llc10% ownerbought200at $13.9515 May 2026filed 15 May 2026
Adar1 Capital Management, Llc10% ownerbought4,081at $13.8013 May 2026filed 15 May 2026
Adar1 Capital Management, Llc10% ownerbought75,178at $14.0013 May 2026filed 15 May 2026
Adar1 Capital Management, Llc10% ownerbought800at $13.8312 May 2026filed 13 May 2026
Adar1 Capital Management, Llc10% ownerbought5,100at $14.0011 May 2026filed 13 May 2026
Adar1 Capital Management, Llc10% ownerbought25,000at $14.0011 May 2026filed 13 May 2026
Adar1 Capital Management, Llc10% ownerbought19,900at $14.0011 May 2026filed 13 May 2026
Adar1 Capital Management, Llc10% ownerbought35,101at $14.005 May 2026filed 6 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders37+1 on the quarter
New · exited10 · 9
Reported value$76.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
CITADEL ADVISORS LLCadded · filed 14 Aug 20267,705,787$12.7M+7,685,901+38649.8%
ADAR1 Capital Management, LLCadded · filed 14 Aug 2026926,352$14.8M+905,817+4411.1%
FMR LLCadded · filed 13 Aug 2026794,720$12.7M+1,269+0.2%
VIKING GLOBAL INVESTORS LPunchanged · filed 14 Aug 2026524,347$8.4M00.0%
TPG GP A, LLCunchanged · filed 14 Aug 2026378,551$6.1M00.0%
Pivotal bioVenture Partners Investment Advisor LLCunchanged · filed 13 Aug 2026300,579$4.8M00.0%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026199,907$3.2M+43,380+27.7%
Nantahala Capital Management, LLCreduced · filed 14 Aug 2026188,422$3.0M-112,213−37.3%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026172,497$2.8M+60,457+54.0%
Almitas Capital LLCreduced · filed 17 Aug 2026120,682$1.9M-70,524−36.9%
31 Mar 2023 – 30 Jun 2026
374859Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Robert Lorne Hopfner Company insiderDirector · last 12 Oct 20261 · 0
Jonathan I. Lieber Company insiderChief Financial Officer · last 9 Oct 20261 · 1
Stephen Uden Company insiderChief Executive Officer · last 6 Oct 20262 · 0
Hui Liu Company insiderDirector · last 24 Sep 20260 · 0
Wendy Chung Company insiderDirector · last 16 Sep 20260 · 0
Helen M. Boudreau Company insiderDirector · last 6 Jul 20260 · 0
ADAR1 Capital Management, LLC Company insider10% owner · last 19 May 20268 · 0
Daniel Schneeberger Company insider10% owner · last 15 May 20264 · 0
Martin Mackay Company insiderDirector · last 18 Feb 20262 · 0
Ronald Hunt Company insiderDirector · last 18 Feb 20261 · 0
Christine A. Nash Company insiderDirector · last 13 May 20250 · 0
Paula Soteropoulos Company insiderDirector · last 13 May 20250 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-57.0%
Share count trendFY 2025 · to 6 Mar 20260.1%
Cash and equivalentsFY 2025 · to 31 Dec 2025$31.4M

Analyst forecasts

No analyst forecasts yet.